The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren plans to start on ...

One assay applies to bioprocesses that use the HEK293 human embryonic kidney cell line, often used in gene therapy development.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Additionally, improving CAR-T biological efficiency could reduce dosing needs, further cutting costs and expanding access.

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

A new study in Human Gene Therapy describes a machine learning (ML) model that can be used as a surrogate for laborious in ...

Genome editing has progressed rapidly, showing promising outcomes for the treatment of genetic disorders, yet there remains ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

A new collaboration facility, opened by Thermo Fisher Scientific, will work to make cell therapy developers’ research more ...